Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma	mucosal melanoma	Not yet recruiting	Phase 2	2025-11-19		NCT07236528

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	164

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials